Clinical Trial Update: Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of sunitinib, irinotecan, fluorouracil, and leucovorin in advanced gastric and esophageal cancers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• Sunitinib (sunitinib)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Esophageal Cancer, Gastric Cancer | Phase 1 | Status: TERMINATED